Hepatitis C Virus
Showing 26 - 50 of 95
Non-alcoholic Steatohepatitis, Chronic Liver Disease, HCV Trial in Worldwide (Eltrombopag, Placebo)
Terminated
- Non-alcoholic Steatohepatitis
- +10 more
- Eltrombopag
- Placebo
-
Birmingham, Alabama
- +106 more
Sep 13, 2018
Hepatitis C Virus Trial (Grazoprevir (GZR), Elbasvir (EBR), Ribavirin (RBV))
Completed
- Hepatitis C Virus
- Grazoprevir (GZR)
- +2 more
- (no location specified)
Aug 23, 2018
Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-450/ritonavir (r), ABT-530, Ribavirin (RBV))
Completed
- Chronic Hepatitis C
- Hepatitis C Virus
- ABT-450/ritonavir (r)
- +2 more
- (no location specified)
Jan 25, 2018
Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir, Ribavirin)
Completed
- Chronic Hepatitis C
- +4 more
- (no location specified)
Oct 13, 2017
Chronic Hepatitis C, Cirrhosis, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, Ribavirin)
Completed
- Chronic Hepatitis C
- +2 more
- ombitasvir/paritaprevir/ritonavir and dasabuvir
- Ribavirin
- (no location specified)
Sep 14, 2017
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530, ribavirin (RBV), ABT-493/ABT-530)
Completed
- Chronic Hepatitis C
- +3 more
- ABT-493, ABT-530
- +2 more
- (no location specified)
Aug 17, 2017
Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, ribavirin)
Completed
- Hepatitis C Virus
- (no location specified)
Aug 1, 2017
Chronic Hepatitis C, Decompensated Cirrhosis, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir, ribavirin)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jun 9, 2017
Hepatitis C Virus, Advanced Fibrosis, Cirrhosis Trial in United States (PEG -Intron, Colchicine)
Completed
- Hepatitis C Virus
- +2 more
- PEG -Intron
- Colchicine
-
Birmingham, Alabama
- +48 more
Jun 11, 2017
Hepatitis C Virus Infection and Hematologic and Thyroid Cancers
Completed
- Hepatitis C Virus
-
Houston, TexasHouston Veterans AFfairs Medical Center
Jun 30, 2017
Describe the Actual Situation of Hepatitis C Treatment in Brazil
Completed
- Hepatitis C Virus
-
Goiânia, Brazil
- +7 more
May 5, 2017
Hepatitis C Virus Trial in Canada, United States (Simeprevir 150 mg, Daclatasvir 60 mg, Sofosbuvir 400 mg)
Completed
- Hepatitis C Virus
- Simeprevir 150 mg
- +2 more
-
Bakersfield, California
- +7 more
Jan 11, 2017
Hepatitis C Virus Trial in Worldwide (Daclatasvir, Simeprevir, Ribavirin)
NS3/4a Protease and NS5A Protein of Hepatitis C Virus in
Completed
- Hepatitis C Virus
-
Belém, Brazil
- +5 more
Feb 3, 2017
Intrahepatic Hepatitis C Virus RNA Levels at Time of Liver
Unknown status
- Hepatitis C Virus
- Liver Transplantation
-
New York, New YorkMount Sinai School of Medicine Recanati/Miller Transplantation I
Jan 27, 2017
HCV Care Pathway in Ile-de-France
Unknown status
- Hepatitis C Virus
- No intervention
-
Creteil, FranceHenri Mondor Hospital
Sep 1, 2016
Health Care Management and Health Outcomes of Hepatitis C Virus
Completed
- Hepatitis C Virus
- No intervention
-
Phoenix, Arizona
- +32 more
Feb 19, 2016
Hepatitis C Virus Trial in Changchun (interferon)
Completed
- Hepatitis C Virus
-
Changchun, Jilin, ChinaPhase One Clinical Trial ward, First Hospital, Jilin University
Jan 23, 2016
Hepatitis C Virus Trial in Worldwide (Placebo, Daclatasvir, Pegylated interferon alfa-2a)
Completed
- Hepatitis C Virus
- Placebo
- +3 more
-
Los Angeles, California
- +25 more
Nov 10, 2015
Hepatitis C Virus Trial in Worldwide (Daclatasvir, Placebo, peg-interferon alfa-2a)
Hepatitis C Virus Trial in Shiraz (150 mg/daily chloroquine compare to for 12 week, Chloroquine, )
Completed
- Hepatitis C Virus
- 150 mg/daily chloroquine compare to placebo for 12 week
- +2 more
-
Shiraz, Fars, Iran, Islamic Republic ofHealth Policy Research Center
Oct 18, 2015